What You Should Have Asked Your Teachers About Xarelto Lawsuit
Our attorneys have filed a mass tort lawsuit on behalf of individuals who took the blood thinner Xarelto (rivaroxaban) and suffered serious bleeding events. Pharmaceutical businesses, such as the makers of Xarelto, have a duty to make sure that their drugs are reasonably secure for use - and failure to accomplish so might be grounds for compensation. Our lawyers are functioning hard to acquire these hurt by the drug the compensation they are entitled to.
Although bleeding can be a widespread complication associated with anticoagulants, it has been alleged that Xarelto is far more hazardous than traditional blood thinners since no antidote exists to reverse its blood-thinning effects. This implies that, inside the occasion of an emergency, sufferers could be at risk for irreversible bleeding problems, which includes life-threatening internal and gastrointestinal hemorrhaging.
Should you or possibly a loved 1 suffered a critical bleeding event following taking Xarelto, you may have legal recourse. For much more details, speak to us these days to have your case reviewed, totally free of charge.
Compensation Possibilities
xarelto-compensation-photoThe plaintiffs in these lawsuits are in search of compensation from Bayer and Janssen for previous and future medical bills, lost wages, discomfort and suffering and, in circumstances of death, funeral expenses. Furthermore, they're searching for punitive damages, that are generally awarded to punish the defendant and deter other companies from acting similarly.
Why Are Lawsuits Becoming Filed?
Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is harmful and defective. The plaintiffs claim that, unlike conventional anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Because of this, the lawsuits claim, doctors have no effective signifies of stopping Xarelto users from bleeding within the occasion of an emergency. Plaintiffs inside the lawsuits allege serious and fatal injuries, which includes cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.
In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:
The manufacturers of Xarelto marketed the drug as a superior in the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.
The makers of the drug continue to market Xarelto as a safe anticoagulant option.
Doctors and healthcare staff were not properly made aware of methods to stabilize and treat a Xarelto user in the event of a bleeding complication.
Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding occasion.
does xarelto require bridging is linked to serious bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing harmful clotting.
Visit this page for a lot more info on the alleged health risks of Xarelto.
Multidistrict Litigation Trial Dates Set
The attorneys within the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.
